Medicaid-Covered Men with Hemophilia Spend Less on Healthcare Than Employer-Insured Peers
Men with hemophilia who have a Medicaid health plan spend less on healthcare than those with employer-sponsored health insurance, due…
Articles by Magdalena Kegel
Young Hemophilia Patients Adhere Well to Prophylactic Treatment, Study Finds
Most young people with moderate or severe hemophilia A and B in France receive long-term prophylactic (preventive) treatment — an approach…
Supportive Environment Seen as a Reason Some Young Hemophiliacs Engage in Risky Sports
Positive mental attitudes and encouragement from family and friends are key reasons young hemophiliacs participate in sports that could increase…
Early Low-Dose Treatment Effective in Preventing Bleeding in Hemophilia A, Study Reports
Low-dose recombinant factor VIII lowered bleeding rates in Chinese children with hemophilia, and the earlier the preventive treatment began, the…
Advances in Hemophilia B Replacement and Gene Therapies Detailed at ASH Meeting
Two presentations at the 2016 American Society of Hematology Annual Meeting (ASH) highlight ongoing treatment advances for hemophilia B.
Preventive Hemophilia Treatment Still Faces Obstacles, but Future Looks Promising
Prophylactic hemophilia treatment can save patients with severe forms of the disease from the long-term consequences of joint damage and…
New Model Might Improve Hemophilia Factor VIII Treatment After Surgery
Researchers have created a model for how factor VIII replacement concentrates behave in the body of hemophilia A patients undergoing surgery,…
Clinical Trial Results of 3 Hemophilia Treatments, Two Now in Use, Published
Key findings from clinical trials of three recombinant coagulation factors as new hemophilia treatments, presented at last year’s Congress of…